FR2832711B1 - Derives de triazolo [4,3-a] pyrido [2,3-d] pyrimidin-5-ones, compositions les contenant, procede de preparation et utilisation - Google Patents

Derives de triazolo [4,3-a] pyrido [2,3-d] pyrimidin-5-ones, compositions les contenant, procede de preparation et utilisation

Info

Publication number: FR2832711B1
Authority: FR; France
Prior art keywords: triazolo; pyrido; pyrimidin; preparation; compositions containing
Prior art date: 2001-11-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

FR0115249A

Other languages

English (en)

Other versions

FR2832711A1 (fr

Inventor

Bernard Gaudilliere

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Warner Lambert Co LLC

Original Assignee

Warner Lambert Co LLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-26

Filing date

2001-11-26

Publication date

2004-01-30

2001-11-26 Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC

2001-11-26 Priority to FR0115249A priority Critical patent/FR2832711B1/fr

2002-11-04 Priority to TW091132503A priority patent/TW200300344A/zh

2002-11-22 Priority to SV2002001410A priority patent/SV2003001410A/es

2002-11-22 Priority to UY27546A priority patent/UY27546A1/es

2002-11-22 Priority to US10/303,103 priority patent/US6787554B2/en

2002-11-22 Priority to PE2002001123A priority patent/PE20030664A1/es

2002-11-22 Priority to PA20028558301A priority patent/PA8558301A1/es

2002-11-25 Priority to AU2002361407A priority patent/AU2002361407A1/en

2002-11-25 Priority to PCT/EP2002/014184 priority patent/WO2003045951A1/fr

2002-11-25 Priority to MXPA04004429A priority patent/MXPA04004429A/es

2002-11-25 Priority to EP02796623A priority patent/EP1451190A1/fr

2002-11-25 Priority to JP2003547401A priority patent/JP2005529843A/ja

2002-11-25 Priority to CA002468071A priority patent/CA2468071A1/fr

2002-11-25 Priority to BR0214439-5A priority patent/BR0214439A/pt

2002-11-25 Priority to ARP020104520A priority patent/AR038003A1/es

2002-11-26 Priority to HN2002000327A priority patent/HN2002000327A/es

2003-05-30 Publication of FR2832711A1 publication Critical patent/FR2832711A1/fr

2004-01-30 Application granted granted Critical

2004-01-30 Publication of FR2832711B1 publication Critical patent/FR2832711B1/fr

2021-11-26 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Cardiology (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Oncology (AREA)
Dermatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Communicable Diseases (AREA)
Pain & Pain Management (AREA)
Virology (AREA)
Transplantation (AREA)
Psychiatry (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Anesthesiology (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

FR0115249A 2001-11-26 2001-11-26 Derives de triazolo [4,3-a] pyrido [2,3-d] pyrimidin-5-ones, compositions les contenant, procede de preparation et utilisation Expired - Fee Related FR2832711B1 (fr)

Priority Applications (16)

Application Number	Priority Date	Filing Date	Title
FR0115249A FR2832711B1 (fr)	2001-11-26	2001-11-26	Derives de triazolo [4,3-a] pyrido [2,3-d] pyrimidin-5-ones, compositions les contenant, procede de preparation et utilisation
TW091132503A TW200300344A (en)	2001-11-26	2002-11-04	Triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-one derivatives, compositions containing them, method of preparation and use
UY27546A UY27546A1 (es)	2001-11-26	2002-11-22	Derivados de triazolo (4,3-a) pirido (2,3-d) pirimidin-5-ona, composiciones que los contienen, metodo de preparación y uso.
US10/303,103 US6787554B2 (en)	2001-11-26	2002-11-22	Triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-one derivatives
PE2002001123A PE20030664A1 (es)	2001-11-26	2002-11-22	DERIVADOS DE TRIAZOLO [4,3-a]PIRIDO[2,3-d]PIRIMIDIN-5-ONA, COMPOSICIONES QUE LOS CONTIENEN, METODO DE PREPARACION Y USO
PA20028558301A PA8558301A1 (es)	2001-11-26	2002-11-22	DERIVADOS DE TRIAZOLO [4,3-a] PIRIDO [2,3-d] PIRIMIDIN-5-ONA, COMPOSICIONES QUE LOS CONTIENEN, METODO DE PREPARACION Y USO.
SV2002001410A SV2003001410A (es)	2001-11-26	2002-11-22	Derivados de triazolo [4,3-a] pirido [2,3-d] pirimidin-5-ona, composiciones que los contienen, metodo de preparacion y uso
ARP020104520A AR038003A1 (es)	2001-11-26	2002-11-25	Compuesto de triazolo[4,3-a]pirido(2,3-d)pirimidin-5-ona, composiciones que lo contienen, metodo de preparacion y su uso
AU2002361407A AU2002361407A1 (en)	2001-11-26	2002-11-25	Triazolo(4,3-a)pyrido(2,3-d)pyrimidin-5-one derivatives, compositions containing same, preparation method and use thereof
EP02796623A EP1451190A1 (fr)	2001-11-26	2002-11-25	DERIVES DE TRIAZOLO(4,3-a)PYRIDO(2,3-d)PYRIMIDIN-5-ONES, COMPOSITIONS LES CONTENANT, PROCEDE DE PREPARATION ET UTILISATION
JP2003547401A JP2005529843A (ja)	2001-11-26	2002-11-25	トリアゾロ［４，３−ａ］ピリド［２，３−ｄ］ピリミジン−５−オン、それらを含有する組成物、その製造方法及び使用
CA002468071A CA2468071A1 (fr)	2001-11-26	2002-11-25	Derives de triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-ones, compositions les contenant, procede de preparation et utilisation
BR0214439-5A BR0214439A (pt)	2001-11-26	2002-11-25	Derivados de triazolo[4,3-a]pirido[2,3-d]pirimidin-5-onas, composições que os contêm, processo de preparação e utilização
PCT/EP2002/014184 WO2003045951A1 (fr)	2001-11-26	2002-11-25	DERIVES DE TRIAZOLO[4,3-a]PYRIDO[2,3-d]PYRIMIDIN-5-ONES, COMPOSITIONS LES CONTENANT, PROCEDE DE PREPARATION ET UTILISATION
MXPA04004429A MXPA04004429A (es)	2001-11-26	2002-11-25	Derivados de triazolo[4,3-a]pirido[2,3-d]pirimidin-5-ona, composiciones que los contienen, metodo de preparacion y uso.
HN2002000327A HN2002000327A (es)	2001-11-26	2002-11-26	DERIVADOS DE TRIAZOLO [4, 3-a] PIRIDO [2, 3-d] PIRIMIDIN-5-ONA, COMPOSICIONES QUE LOS CONTIENEN, METODO DE PREPARACION Y USO

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0115249A FR2832711B1 (fr)	2001-11-26	2001-11-26	Derives de triazolo [4,3-a] pyrido [2,3-d] pyrimidin-5-ones, compositions les contenant, procede de preparation et utilisation

Publications (2)

Publication Number	Publication Date
FR2832711A1 FR2832711A1 (fr)	2003-05-30
FR2832711B1 true FR2832711B1 (fr)	2004-01-30

Family

ID=8869777

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR0115249A Expired - Fee Related FR2832711B1 (fr)	2001-11-26	2001-11-26	Derives de triazolo [4,3-a] pyrido [2,3-d] pyrimidin-5-ones, compositions les contenant, procede de preparation et utilisation

Country Status (16)

Country	Link
US (1)	US6787554B2 (fr)
EP (1)	EP1451190A1 (fr)
JP (1)	JP2005529843A (fr)
AR (1)	AR038003A1 (fr)
AU (1)	AU2002361407A1 (fr)
BR (1)	BR0214439A (fr)
CA (1)	CA2468071A1 (fr)
FR (1)	FR2832711B1 (fr)
HN (1)	HN2002000327A (fr)
MX (1)	MXPA04004429A (fr)
PA (1)	PA8558301A1 (fr)
PE (1)	PE20030664A1 (fr)
SV (1)	SV2003001410A (fr)
TW (1)	TW200300344A (fr)
UY (1)	UY27546A1 (fr)
WO (1)	WO2003045951A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2275095A3 (fr)	2005-08-26	2011-08-17	Braincells, Inc.	Neurogenese par modulation des recepteurs muscariniques
EP2258359A3 (fr)	2005-08-26	2011-04-06	Braincells, Inc.	Neurogenèse par modulation des récepteurs muscariniques avec sabcomeline
CA2625153A1 (fr)	2005-10-21	2007-04-26	Braincells, Inc.	Modulation de la neurogenese par inhibition de la pde
CA2625210A1 (fr)	2005-10-31	2007-05-10	Braincells, Inc.	Modulation de la neurogenese dont la mediation est assuree par recepteur gaba
JP2009514969A (ja)	2005-11-09	2009-04-09	コンビナトアールエックスインコーポレーティッド	医学的状態を治療するための方法、組成物、およびキット
US20100216734A1 (en)	2006-03-08	2010-08-26	Braincells, Inc.	Modulation of neurogenesis by nootropic agents
US7678808B2 (en)	2006-05-09	2010-03-16	Braincells, Inc.	5 HT receptor mediated neurogenesis
JP2009536669A (ja)	2006-05-09	2009-10-15	ブレインセルス，インコーポレイティド	アンジオテンシン調節による神経新生
AU2007292848A1 (en)	2006-09-08	2008-03-13	Braincells, Inc.	Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en)	2006-09-19	2010-07-22	Braincells, Inc.	Modulation of neurogenesis by ppar agents
WO2010099217A1 (fr)	2009-02-25	2010-09-02	Braincells, Inc.	Modulation de neurogenèse à l'aide de combinaisons de d-cyclosérine
EP2266985A1 (fr) *	2009-06-26	2010-12-29	Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts	Dérivés de pyrimidine tricycliques en tant qu'antagonistes Wnt
WO2013106547A1 (fr)	2012-01-10	2013-07-18	President And Fellows Of Harvard College	Composés promoteurs de réplication des cellules bêta et leurs procédés d'utilisation
MD20150071A2 (ro)	2013-02-19	2016-02-29	Pfizer Inc.	Compuşi azabenzimidazolici ca inhibitori ai PDE4 izoenzimelor pentru tratamentul tulburărilor SNC şi altor afecţiuni
RU2659070C9 (ru) *	2014-04-23	2018-08-24	Дарт Нейросайенс (Кайман) Лтд.	ЗАМЕЩЕННЫЕ [1,2,4]ТРИАЗОЛО[1,5-a]ПИРИМИДИН-7-ИЛЬНЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ PDE2
US10131669B2 (en)	2014-07-24	2018-11-20	Pfizer Inc.	Pyrazolopyrimidine compounds
HUE044040T2 (hu)	2014-08-06	2019-09-30	Pfizer	Imidazopiridazin vegyületek
EP3201196B1 (fr)	2014-10-03	2021-07-28	UCB Biopharma SRL	Dérivés d'imidazoles pentacyclic fusionnés
US10183934B2 (en)	2015-02-02	2019-01-22	Forma Therapeutics, Inc.	Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors
SG11201708622UA (en)	2015-02-02	2017-11-29	Forma Therapeutics Inc	3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as hdac inhibitors
TN2017000485A1 (en) *	2015-06-17	2019-04-12	Pfizer	Tricyclic compounds and their use as phosphodiesterase inhibitors
WO2017218950A1 (fr)	2016-06-17	2017-12-21	Forma Therapeutics, Inc.	Indanes d'acide hydroxamique 2-spiro-5 et 6 utilisés en tant qu'inhibiteurs de hdac

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL66835A (en)	1981-09-24	1988-05-31	Roussel Uclaf	1,4-disubstituted(1,2,4)triazolo(4,3-alpha)quinazolin-5(4h)-one derivatives and their salts,their preparation and pharmaceutical compositions containing them
DE3601731A1 (de)	1986-01-22	1987-07-23	Merck Patent Gmbh	Pyrimidinderivate
US4808587A (en)	1986-04-16	1989-02-28	Nippon Zoki Pharmaceutical Co., Ltd.	5-substituted pyrido[2,3-d]pyrimidine-2,4-diones
DE3738844A1 (de)	1987-11-16	1989-05-24	Merck Patent Gmbh	Analgetikum
DE4035479A1 (de)	1990-11-08	1992-05-14	Basf Ag	Substituierte pyrido (2,3-d)pyrimidin-2,4(1h,3h)-dione
ES2137113B1 (es) *	1997-07-29	2000-09-16	Almirall Prodesfarma Sa	Nuevos derivados de triazolo-piridazinas heterociclicos.
JP2000119272A (ja)	1998-10-15	2000-04-25	Nippon Zoki Pharmaceut Co Ltd	新規７−アミノピリド〔２，３−ｄ〕ピリミジン誘導体
FR2792938B1 (fr) *	1999-04-28	2001-07-06	Warner Lambert Co	NOUVELLES 1-AMINO TRIAZOLO [4,3-a] QUINAZOLINE-5-ONES INHIBITRICES DE PHOSPHODIESTERASES IV
TWI243055B (en)	2000-04-13	2005-11-11	Nippon Zoki Pharmaceutical Co	Pharmaceutical composition for use in treatment of dermatitis

2001
- 2001-11-26 FR FR0115249A patent/FR2832711B1/fr not_active Expired - Fee Related
2002
- 2002-11-04 TW TW091132503A patent/TW200300344A/zh unknown
- 2002-11-22 PE PE2002001123A patent/PE20030664A1/es not_active Application Discontinuation
- 2002-11-22 SV SV2002001410A patent/SV2003001410A/es not_active Application Discontinuation
- 2002-11-22 US US10/303,103 patent/US6787554B2/en not_active Expired - Fee Related
- 2002-11-22 PA PA20028558301A patent/PA8558301A1/es unknown
- 2002-11-22 UY UY27546A patent/UY27546A1/es not_active Application Discontinuation
- 2002-11-25 BR BR0214439-5A patent/BR0214439A/pt not_active IP Right Cessation
- 2002-11-25 WO PCT/EP2002/014184 patent/WO2003045951A1/fr not_active Ceased
- 2002-11-25 JP JP2003547401A patent/JP2005529843A/ja active Pending
- 2002-11-25 AU AU2002361407A patent/AU2002361407A1/en not_active Abandoned
- 2002-11-25 AR ARP020104520A patent/AR038003A1/es not_active Application Discontinuation
- 2002-11-25 CA CA002468071A patent/CA2468071A1/fr not_active Abandoned
- 2002-11-25 EP EP02796623A patent/EP1451190A1/fr not_active Withdrawn
- 2002-11-25 MX MXPA04004429A patent/MXPA04004429A/es not_active Application Discontinuation
- 2002-11-26 HN HN2002000327A patent/HN2002000327A/es unknown

Also Published As

Publication number	Publication date
EP1451190A1 (fr)	2004-09-01
AR038003A1 (es)	2004-12-22
BR0214439A (pt)	2004-11-03
TW200300344A (en)	2003-06-01
CA2468071A1 (fr)	2003-06-05
PE20030664A1 (es)	2003-08-28
JP2005529843A (ja)	2005-10-06
FR2832711A1 (fr)	2003-05-30
US20030187257A1 (en)	2003-10-02
PA8558301A1 (es)	2003-09-17
WO2003045951A1 (fr)	2003-06-05
HN2002000327A (es)	2003-06-09
MXPA04004429A (es)	2005-05-16
AU2002361407A1 (en)	2003-06-10
SV2003001410A (es)	2003-04-03
US6787554B2 (en)	2004-09-07
UY27546A1 (es)	2003-06-30

Publication	Publication Date	Title
FR2832711B1 (fr)	2004-01-30	Derives de triazolo [4,3-a] pyrido [2,3-d] pyrimidin-5-ones, compositions les contenant, procede de preparation et utilisation
HUP0202494A3 (en)	2003-10-28	Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0105081A3 (en)	2004-11-29	Triazolo[4,5-d]pyrimidine derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP0203450A3 (en)	2003-05-28	Pyrazolo '4,3-d! pyrimidine derivatives, process for their preparation and pharmaceutical compositions containing them and their use
HUP0402018A3 (en)	2008-06-30	5-amino-7h-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine derivatives, their use and pharmaceutical compositions containing them
ATE380031T1 (de)	2007-12-15	Pyrrolo 2,3-d pyrimidinderivate enthaltende zusammensetzungen
HUP0200450A3 (en)	2004-04-28	Cephen derivatives containing an imidazo[4,5-b]pyridiniummethyl moiety, process for their preparation and pharmaceutical compositions of the same
HUP0204410A3 (en)	2003-07-28	Pyrimidine-4-one derivatives, process for their preparation, pharmaceutical compositions containing them and their use
NO20000394D0 (no)	2000-01-26	1,2,4-triazolo[4,3-B]pyrido[3,2-D]pyridazinderivater samt farmasoeytiske sammensetninger inneholdende slike
HUP0400692A3 (en)	2007-09-28	Substituted 7h-pyrrolo[2,3-d]pyrimidine derivatives, their use and pharmaceutical compositions containing them
ID29514A (id)	2001-09-06	2-ARIL-3-(HETEROARIL)-IMIDAZO [1,2-a]PIRIMIDIN TERSUBSTITUSI, DAN METODE-METODE DAN KOMPOSISI-KOMPOSISI FARMASI YANG TERKAIT
HUP0001507A3 (en)	2002-01-28	Pyrrolo [2,3-d] pyrimidine derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP0100202A3 (en)	2001-10-29	Novel triazolo[4,5-d]pyrimidine derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP0204246A3 (en)	2006-01-30	Novel thiazolo[4,5-d]pyrimidine compounds, process for their preparation, pharmaceutical compositions containing them and their use
HUP0203438A3 (en)	2003-05-28	5-(2-substituted-5-heterocyclysulphonylpyrid-3-yl)-dihydropyrazolo[4,3-d]pyrimidin-7-ones as phosphodiesterase inhibitors, process for their preparation and pharmaceutical compositions containing them
HUP0303350A3 (en)	2006-02-28	Use of substituted imidazo[1,2-a]pyridine-, imidazo[1,2-a]pyrimidine and imidazo[1,2-a]pyrazine-3-yl-amine derivatives for producing nos-inhibiting pharmaceutical compositions
IL169335A0 (en)	2007-07-04	PYRAZOLO[3,4,-b] PYRIDINE COMPOUNDS, AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS
HUP0301114A3 (en)	2004-11-29	Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents and pharmaceutical compositions containing them
IL191960A (en)	2015-11-30	History of imidazo [5,1– a] pyridine and pharmaceutical preparations containing them
HUP0204431A3 (en)	2006-01-30	1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use, process for their preparation and pharmaceutical compositions containing them
HUP0500332A3 (en)	2009-12-28	Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)-one derivatives, their use and pharmaceutical compositions containing them
HUP0401292A3 (en)	2011-01-28	Pyrazolo[1,5-a]pyridines, pharmaceutical compositions containing the same and process for preparation thereof
HUP0204141A3 (en)	2005-03-29	Pyrido[2,3d]pyrimidine-2,7-diamine inhibitors, pharmaceutical compositions containing them and their use
HUP0003826A3 (en)	2001-11-28	Novel triazolo [4,5-b] pyrimidine derivatives, process for their preparation and pharmaceutical compositions thereof
HUP0500328A3 (en)	2009-12-28	Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)-one derivatives, their use and pharmaceutical compositions containing them

Legal Events

Date	Code	Title	Description
2008-11-14	ST	Notification of lapse	Effective date: 20080930